Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells

Malignant progression in cancer requires populations of tumor-initiating cells (TICs) endowed with unlimited self renewal, survival under stress, and establishment of distant metastases. Additionally, the acquisition of invasive properties driven by epithelial-mesenchymal transition (EMT) is critica...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of clinical investigation Jg. 122; H. 5; S. 1849 - 1868
Hauptverfasser: Celia-Terrassa, Toni, Meca-Cortes, Oscar, Mateo, Francesca, De Paz, Alexia Martinez, Rubio, Nuria, Arnal-Estape, Anna, Ell, Brian J, Bermudo, Raquel, Diaz, Alba, Guerra-Rebollo, Marta, Lozano, Juan Jose, Estaras, Conchi, Ulloa, Catalina, Alvarez-Simon, Daniel, Mila, Jordi, Vilella, Ramon, Paciucci, Rosanna, Martinez-Balbas, Marian, De Herreros, Antonio Garcia, Gomis, Roger R, Kang, Yibin, Blanco, Jeronimo, Fernondez, Pedro L, Thomson, Timothy M
Format: Journal Article
Sprache:Englisch
Veröffentlicht: American Society for Clinical Investigation 01.05.2012
Schlagworte:
ISSN:0021-9738
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Malignant progression in cancer requires populations of tumor-initiating cells (TICs) endowed with unlimited self renewal, survival under stress, and establishment of distant metastases. Additionally, the acquisition of invasive properties driven by epithelial-mesenchymal transition (EMT) is critical for the evolution of neoplastic cells into fully metastatic populations. Here, we characterize 2 human cellular models derived from prostate and bladder cancer cell lines to better understand the relationship between TIC and EMT programs in local invasiveness and distant metastasis. The model tumor subpopulations that expressed a strong epithelial gene program were enriched in highly metastatic TICs, while a second subpopulation with stable mesenchymal traits was impoverished in TICs. Constitutive overexpression of the transcription factor Snai1 in the epithelial/TIC-enriched populations engaged a mesenchymal gene program and suppressed their self renewal and metastatic phenotypes. Conversely, knockdown of EMT factors in the mesenchymal-like prostate cancer cell subpopulation caused a gain in epithelial features and properties of TICs. Both tumor cell subpopulations cooperated so that the nonmetastatic mesenchymal-like prostate cancer subpopulation enhanced the in vitro invasiveness of the metastatic epithelial subpopulation and, in vivo, promoted the escape of the latter from primary implantation sites and accelerated their metastatic colonization. Our models provide new insights into how dynamic interactions among epithelial, self-renewal, and mesenchymal gene programs determine the plasticity of epithelial TICs.
AbstractList Malignant progression in cancer requires populations of tumor-initiating cells (TICs) endowed with unlimited self renewal, survival under stress, and establishment of distant metastases. Additionally, the acquisition of invasive properties driven by epithelial-mesenchymal transition (EMT) is critical for the evolution of neoplastic cells into fully metastatic populations. Here, we characterize 2 human cellular models derived from prostate and bladder cancer cell lines to better understand the relationship between TIC and EMT programs in local invasiveness and distant metastasis. The model tumor subpopulations that expressed a strong epithelial gene program were enriched in highly metastatic TICs, while a second subpopulation with stable mesenchymal traits was impoverished in TICs. Constitutive overexpression of the transcription factor Snai1 in the epithelial/TIC-enriched populations engaged a mesenchymal gene program and suppressed their self renewal and metastatic phenotypes. Conversely, knockdown of EMT factors in the mesenchymal-like prostate cancer cell subpopulation caused a gain in epithelial features and properties of TICs. Both tumor cell subpopulations cooperated so that the nonmetastatic mesenchymal-like prostate cancer subpopulation enhanced the in vitro invasiveness of the metastatic epithelial subpopulation and, in vivo, promoted the escape of the latter from primary implantation sites and accelerated their metastatic colonization. Our models provide new insights into how dynamic interactions among epithelial, self-renewal, and mesenchymal gene programs determine the plasticity of epithelial TICs.
Audience Academic
Author Lozano, Juan Jose
Guerra-Rebollo, Marta
Ulloa, Catalina
Vilella, Ramon
Estaras, Conchi
Mila, Jordi
Fernondez, Pedro L
Celia-Terrassa, Toni
Thomson, Timothy M
Rubio, Nuria
Meca-Cortes, Oscar
Diaz, Alba
Gomis, Roger R
Ell, Brian J
Kang, Yibin
Mateo, Francesca
Paciucci, Rosanna
Bermudo, Raquel
Martinez-Balbas, Marian
Arnal-Estape, Anna
De Paz, Alexia Martinez
Alvarez-Simon, Daniel
Blanco, Jeronimo
De Herreros, Antonio Garcia
Author_xml – sequence: 1
  fullname: Celia-Terrassa, Toni
– sequence: 2
  fullname: Meca-Cortes, Oscar
– sequence: 3
  fullname: Mateo, Francesca
– sequence: 4
  fullname: De Paz, Alexia Martinez
– sequence: 5
  fullname: Rubio, Nuria
– sequence: 6
  fullname: Arnal-Estape, Anna
– sequence: 7
  fullname: Ell, Brian J
– sequence: 8
  fullname: Bermudo, Raquel
– sequence: 9
  fullname: Diaz, Alba
– sequence: 10
  fullname: Guerra-Rebollo, Marta
– sequence: 11
  fullname: Lozano, Juan Jose
– sequence: 12
  fullname: Estaras, Conchi
– sequence: 13
  fullname: Ulloa, Catalina
– sequence: 14
  fullname: Alvarez-Simon, Daniel
– sequence: 15
  fullname: Mila, Jordi
– sequence: 16
  fullname: Vilella, Ramon
– sequence: 17
  fullname: Paciucci, Rosanna
– sequence: 18
  fullname: Martinez-Balbas, Marian
– sequence: 19
  fullname: De Herreros, Antonio Garcia
– sequence: 20
  fullname: Gomis, Roger R
– sequence: 21
  fullname: Kang, Yibin
– sequence: 22
  fullname: Blanco, Jeronimo
– sequence: 23
  fullname: Fernondez, Pedro L
– sequence: 24
  fullname: Thomson, Timothy M
BookMark eNqN0M9rwjAUB_AcHEzdDvsPAjvtUJc0qW2OIm46BGG_rvIaX2skTaVJYfvvF9gYEzyMwMvj8fk-SEZk4FqHhNxwNuE8T--f5qtMpbyYDMiQsZQnKhfFJRl5f2CMS5nJITksjibs0RqwSYMend5_NmBp6MB5E0zrqAZHfX88dug9beDQdhRC6EzZB_S0rei-byLB30U09E3bJcbFPATjaqrRWn9FLiqwHq9_7jF5e1i8zpfJevO4ms_WSc1zoZKpBsjEVGRCMiUKzaosA1FCVfCsLGNTyGkqtExZrotqF2t0mOfAS8w5lGJMbr_31mBxa1zVxsfoxni9naWFkiJVUkWVnFE1OuzAxn-sTByf-MkZH88OG6PPBu5OAtEE_Ag19N5vVy_P_7eb97_2CxRylVw
ContentType Journal Article
Copyright COPYRIGHT 2012 American Society for Clinical Investigation
Copyright_xml – notice: COPYRIGHT 2012 American Society for Clinical Investigation
DBID IOV
ISR
DOI 10.1172/JCI59218.
DatabaseName Gale In Context: Opposing Viewpoints
Gale In Context: Science
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID A289432949
GroupedDBID ---
-~X
.55
.XZ
08G
08P
29K
354
36B
5GY
5RE
5RS
7RV
7X7
88E
8AO
8F7
8FE
8FH
8FI
8FJ
8R4
8R5
AAWTL
ABOCM
ABPMR
ABUWG
ACGFO
ACIHN
ACNCT
ACPRK
ADBBV
ADPDF
AEAQA
AENEX
AFCHL
AFFHD
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ASPBG
AVWKF
AZFZN
BAWUL
BBNVY
BCR
BCU
BEC
BENPR
BHPHI
BKEYQ
BLC
BPHCQ
BVXVI
CCPQU
CS3
D-I
DIK
DU5
E3Z
EBD
EBS
EJD
EMB
EMOBN
EX3
F5P
FRP
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
IOF
IOV
IPO
ISR
ITC
KQ8
L7B
LK8
M1P
M5~
M7P
NAPCQ
OBH
OCB
ODZKP
OFXIZ
OGEVE
OHH
OK1
OVD
OVIDX
OVT
P2P
P6G
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
Q2X
RPM
S0X
SJFOW
SV3
TEORI
TR2
TVE
UKHRP
VVN
W2D
WH7
WOQ
WOW
X7M
XSB
YFH
YHG
YKV
YOC
ZY1
~H1
ID FETCH-LOGICAL-g1739-6caa53635340938c0f55a3baf815bb3ba84623c4207c8fd07c409e77a1be71ab3
ISSN 0021-9738
IngestDate Sat Nov 29 13:03:11 EST 2025
Mon Nov 24 15:52:33 EST 2025
Sun Nov 23 08:56:17 EST 2025
Wed Nov 26 10:10:00 EST 2025
Wed Nov 26 10:04:59 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-g1739-6caa53635340938c0f55a3baf815bb3ba84623c4207c8fd07c409e77a1be71ab3
PageCount 20
ParticipantIDs gale_infotracmisc_A289432949
gale_infotracgeneralonefile_A289432949
gale_infotracacademiconefile_A289432949
gale_incontextgauss_ISR_A289432949
gale_incontextgauss_IOV_A289432949
PublicationCentury 2000
PublicationDate 20120501
PublicationDateYYYYMMDD 2012-05-01
PublicationDate_xml – month: 05
  year: 2012
  text: 20120501
  day: 01
PublicationDecade 2010
PublicationTitle The Journal of clinical investigation
PublicationYear 2012
Publisher American Society for Clinical Investigation
Publisher_xml – name: American Society for Clinical Investigation
SSID ssj0014454
Score 2.0279186
Snippet Malignant progression in cancer requires populations of tumor-initiating cells (TICs) endowed with unlimited self renewal, survival under stress, and...
SourceID gale
SourceType Aggregation Database
StartPage 1849
SubjectTerms Cancer cells
Epithelial tumors
Metastasis
Physiological aspects
Stem cells
Title Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells
Volume 122
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Biological Science Database
  issn: 0021-9738
  databaseCode: M7P
  dateStart: 20020701
  customDbUrl:
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  omitProxy: false
  ssIdentifier: ssj0014454
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  issn: 0021-9738
  databaseCode: 7X7
  dateStart: 20020701
  customDbUrl:
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://search.proquest.com/healthcomplete
  omitProxy: false
  ssIdentifier: ssj0014454
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  issn: 0021-9738
  databaseCode: 7RV
  dateStart: 20020701
  customDbUrl:
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://search.proquest.com/nahs
  omitProxy: false
  ssIdentifier: ssj0014454
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  issn: 0021-9738
  databaseCode: BENPR
  dateStart: 20020701
  customDbUrl:
  isFulltext: true
  dateEnd: 99991231
  titleUrlDefault: https://www.proquest.com/central
  omitProxy: false
  ssIdentifier: ssj0014454
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1db9MwFLXKQIgXxKcGDGQhBA-VoYnjuH5EYYgibUNQUN8qx3ZKpzWpknYa-5P8Ja6dbyjSeOAlitwr2_I9tY-dc68RegHb2BB4akgAPSEJWGxIrDxNwlGggU5oYOCxu2yCHx-PZzPxaTD4WcfCnJ_xNB1fXIj1f3U1lIGzbejsP7i7qRQK4B2cDk9wOzyv5PjDtQ2zOIOGyMqGFqnvP1ZOUQ6LktNnWaHXsNiunQR2uJKnVke5KW--KlPQlhf3maai4Wa7ynKytEIj6XTS9ry_6BLbNsTMkdsm4HLZ5vFoP_hHtlYyNXkO1N2x1ylMLY3vjZIksiJgh7GTQslGQXwE1DirCTdMca3Q6J0BNnxZx-ws5bBMkGAuu-caViDCehqR-oNVV70a1Z2f_NH5OjbBI4KX-WKa-d33O0Bmndkadrdi9zLCbVraj9GECaBAr9u1stYHTE6-9QvLFMK-zWbvi0BcQ9d9zoRdKfisOQGAzSur0oKX3axSXUFzb5rGKm7QYTnTO-h25UH8toTVXTQw6T1086gSYNxHp7vRhVt0YRhNXKMLO3ThFl04S7BDF27RhX9HF3boeoC-vj-cRh9IdV0HWXicChIqKRkFAkuDkaBjNUoYkzSWydhjcQwvQHV9qgJ_xNU40fAEO8O59GLDPRnTh2gvzVKzj7DkWodUB5wmlh9rCbxT61hqRUVMuXiEntsxmtsEJqlVSC3ktijm4JV564O_GX353DN6VRklGQyVklVUCvTDJkbrWb7sWS7KtPC7DA96hjBfq87Pj6_S9yfoVvufOEB7m3xrnqIb6nyzLPJnDlS_AJX8vMk
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epithelial-mesenchymal+transition+can+suppress+major+attributes+of+human+epithelial+tumor-initiating+cells&rft.jtitle=The+Journal+of+clinical+investigation&rft.au=Celia-Terrassa%2C+Toni&rft.au=Meca-Cortes%2C+Oscar&rft.au=Mateo%2C+Francesca&rft.au=De+Paz%2C+Alexia+Martinez&rft.date=2012-05-01&rft.pub=American+Society+for+Clinical+Investigation&rft.issn=0021-9738&rft.volume=122&rft.issue=5&rft.spage=1849&rft_id=info:doi/10.1172%2FJCI59218.&rft.externalDBID=IOV&rft.externalDocID=A289432949
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9738&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9738&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9738&client=summon